The Irish Medical Organisation has criticised planned HSE spending and recruitment controls, warning they could negatively affect patient care and frontline healthcare delivery.
New research published by Minister Jennifer Murnane O’Connor highlights the relationship between social deprivation and addiction treatment demand across Ireland.
Bayer has announced that the HSE has granted hospital pricing approval for EYLEA® 8mg for eligible adult patients with wet age-related macular degeneration and diabetic macular oedema in Ireland.
The first authorised treatment for epidermolysis bullosa in Ireland has been made available, marking a major milestone for patients living with the painful rare skin condition.
Stakeholders at the AXIS Patient Access Conference in Dublin heard that Ireland must agree a clear operational roadmap to meet its 180-day reimbursement decision target.
University Hospital Galway has reached a major milestone in its redevelopment plan, with a design team appointed for two new ward blocks that will deliver 300 additional beds.
Beacon Hospital has launched Ireland’s largest private rheumatology centre, offering integrated diagnostics, infusion therapies and multidisciplinary care to meet rising demand.
Gilead Sciences and Kite have announced the reimbursement of two CAR T-cell therapies in Ireland for eligible adult patients with certain relapsed or refractory blood cancers.